These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21036728)
21. Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model. Kesinger JW; Mehta M; Lerner MR; Brackett DJ; Brueggemeier RW; Li PK; Pento JT Anticancer Res; 2015 Jan; 35(1):47-52. PubMed ID: 25550534 [TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cells. Alderson R; Gohari-Fritsch S; Olsen H; Roschke V; Vance C; Connolly K Cancer Chemother Pharmacol; 2002 Sep; 50(3):202-12. PubMed ID: 12203102 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of growth factors and their receptors as potential therapeutic targets for biliary tract carcinoma. Ojima H J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):319-25. PubMed ID: 22278347 [TBL] [Abstract][Full Text] [Related]
25. E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer. Suzuki M; Saito-Adachi M; Arai Y; Fujiwara Y; Takai E; Shibata S; Seki M; Rokutan H; Maeda D; Horie M; Suzuki Y; Shibata T; Kiyono T; Yachida S Cancer Res; 2021 Jan; 81(2):489-500. PubMed ID: 33293429 [TBL] [Abstract][Full Text] [Related]
26. Attenuation and loss of hormonal modulation of KGF (FGF-7)/KGF receptor expression and mitogenesis during mammary tumor progression. Imagawa W; Pedchenko VK; Helber J; Xing C J Cell Physiol; 2000 Aug; 184(2):222-8. PubMed ID: 10867647 [TBL] [Abstract][Full Text] [Related]
27. Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib. Wiedmann M; Feisthammel J; Blüthner T; Tannapfel A; Kamenz T; Kluge A; Mössner J; Caca K Anticancer Drugs; 2006 Aug; 17(7):783-95. PubMed ID: 16926628 [TBL] [Abstract][Full Text] [Related]
28. Expression of keratinocyte growth factor and its receptor in noncholesteatomatous and cholesteatomatous chronic otitis media. Yamamoto-Fukuda T; Takahashi H; Terakado M; Hishikawa Y; Koji T Otol Neurotol; 2010 Jul; 31(5):745-51. PubMed ID: 20502381 [TBL] [Abstract][Full Text] [Related]
29. Differential regulated expression of keratinocyte growth factor and its receptor in experimental and human liver fibrosis. Otte JM; Schwenger M; Brunke G; Schmitz F; Otte C; Kiehne K; Kloehn S; Mönig H; Schmidt WE; Herzig KH Regul Pept; 2007 Dec; 144(1-3):82-90. PubMed ID: 17692400 [TBL] [Abstract][Full Text] [Related]
30. Keratinocyte growth factor receptor: a therapeutic target in solid cancer. Hong L; Han Y; Liu J; Fan D Expert Opin Ther Targets; 2015; 19(10):1411-8. PubMed ID: 26200212 [TBL] [Abstract][Full Text] [Related]
31. Keratinocyte growth factor-1 expression in healthy and diseased human periodontal tissues. Li M; Firth JD; Putnins EE J Periodontal Res; 2005 Apr; 40(2):118-28. PubMed ID: 15733146 [TBL] [Abstract][Full Text] [Related]
32. Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line. Capone A; Visco V; Belleudi F; Marchese C; Cardinali G; Bellocci M; Picardo M; Frati L; Torrisi MR Cell Growth Differ; 2000 Nov; 11(11):607-14. PubMed ID: 11095249 [TBL] [Abstract][Full Text] [Related]
33. Antisense KGFR oligonucleotide inhibition of KGF-induced motility in breast cancer cells. Zang XP; Lerner MR; Dunn ST; Brackett DJ; Pento JT Anticancer Res; 2003; 23(6C):4913-9. PubMed ID: 14981945 [TBL] [Abstract][Full Text] [Related]
34. Association of stem cell marker expression pattern and survival in human biliary tract cancer. Kemmerling R; Alinger B; Dietze O; Bösmüller HC; Ocker M; Wolkersdörfer GW; Berr F; Neureiter D; Kiesslich T Int J Oncol; 2012 Aug; 41(2):511-22. PubMed ID: 22614781 [TBL] [Abstract][Full Text] [Related]
35. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells. Mayr C; Wagner A; Loeffelberger M; Bruckner D; Jakab M; Berr F; Di Fazio P; Ocker M; Neureiter D; Pichler M; Kiesslich T Oncotarget; 2016 Jan; 7(1):745-58. PubMed ID: 26623561 [TBL] [Abstract][Full Text] [Related]
36. Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma. Chang YT; Hsu C; Jeng YM; Chang MC; Wei SC; Wong JM J Gastroenterol Hepatol; 2007 Mar; 22(3):389-94. PubMed ID: 17295772 [TBL] [Abstract][Full Text] [Related]
37. Hrs regulates the endocytic sorting of the fibroblast growth factor receptor 2b. Belleudi F; Leone L; Maggio M; Torrisi MR Exp Cell Res; 2009 Aug; 315(13):2181-91. PubMed ID: 19362549 [TBL] [Abstract][Full Text] [Related]
38. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia. Danilenko DM; Ring BD; Yanagihara D; Benson W; Wiemann B; Starnes CO; Pierce GF Am J Pathol; 1995 Jul; 147(1):145-54. PubMed ID: 7604876 [TBL] [Abstract][Full Text] [Related]